SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Kokomodo grows real cacao in a lab, no trees required

The software engineer’s role is moving beyond code

Who pays when an AI agent tries again?

Brandlight helps enterprise marketers manage how AI recommends their brand

Buzz

Most popular

Daily

Weekly

1

Serbia opens Israeli drone factory as defense ties with Elbit deepen

2

The man who helped build Palo Alto’s Cortex is leaving the company

3

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

4

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

5

Sayeret Matkal veterans raise $22 million to teach the world English with AI

Biotech

20 stories about Biotech

מטה מודרנה ו מטה מרק MERCK

Moderna stock rockets more than 150% after cancer vaccine succeeds in late-stage trial

19.08.26|Reuters

Moderna's personalized mRNA vaccine, combined with Merck's Keytruda, reduced melanoma recurrence and met a secondary goal for preventing the disease from spreading.

Omnix Medical team

EU backs Israeli antibiotic developer with €8 million grant to combat deadly superbugs

Omnix Medical will lead a European consortium aimed at accelerating late-stage development of its experimental treatment for drug-resistant hospital infections.

Noam Solomon Immunai

Immunai signs up to $15 million research pact with Boehringer Ingelheim

The collaboration focuses on decoding T-cell dysfunction, a common thread linking cancer and autoimmune disorders.

Salignostics founders

Salignostics receives $1.87 million Gates Foundation grant for saliva-based HIV and pregnancy tests

Funding to accelerate non-invasive diagnostics aimed at improving access in developing regions.

מייסדי פיטולון טל זלצר ו חלים ג'ובראן

Phytolon raises $23.6 million Series B to scale natural food color production

26.05.26|Meir Orbach

Israeli biotech targets US market with fermentation-based alternatives to synthetic dyes.

Noam Solomon Immunai

AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million

Biotech company’s immune-system modeling platform will continue supporting oncology drug development through 2027.

ארליך – קולינג קרופס

Israeli startup aims to cool the planet through agriculture

19.04.26|Hagay Gilboa, Maor Shalom Swisa

New technology developed by Cooling Crops lowers crop temperatures and restores degraded soil.

Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development

31.03.26|Meir Orbach

The Israeli startup aims to cut years from protein engineering timelines.

צוות העובדים של Starget Pharma

Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments

18.02.26|Meir Orbach

The Israeli startup is set to launch advanced trials for first-of-its-kind sarcoma treatment in collaboration with MD Anderson.

Converge Bio מפתחת פלטפורמת בינה מלאכותית לגילוי ופיתוח תרופות

Converge Bio raises $25 million Series A to accelerate AI drug discovery

The funding brings total investment to $30 million as the startup works with pharma partners on antibody design and protein optimization.

Arkin raises $100 million biotech fund focused on early clinical science

Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.

וירוס וירוסים חיידק חיידקים בקטריות

BiomX collapses into court proceedings after clinical trial fails

17.12.25|Lital Dobrovitzky

Israeli biotech seeks trustee to manage asset sales amid NIS 11 million debt.

CTech Berlin Conference - Dr. Lior Shaltiel

“To get Israel to a more precise position in biotech, we need to educate our people to become better managers”

07.12.25|Zachy Hennessey

Dr. Lior Shaltiel, CEO of NurExone Biologic, speaks to CTech at Calcalist, CTech and Bank Leumi’s Mind The Tech conference in Berlin.

לייפנפלד )מימין( וכהן־סולל במשרדי NeuroKairs בתל אביב. "יכולנו לשבת כמו כל הסטארט־ אפים באחד ממגדלי ההייטק, אבל חשוב לנו לא להוציא כסף על מה שלא חובה"

The women turning a blood sample into a map of the depressed brain

27.11.25|Sophie Shulman

Tel Aviv-based NeuroKaire is using “brain-in-a-dish” models to personalize antidepressants, and is now shifting from years of research to full-scale commercialization in Israel and the U.S.

Cassidy Bio founders

Cassidy Bio raises $8M Seed round to build AI-first platform for designing genetic medicines

Founders include CRISPR, AI, and biotech veterans focused on improving safety and specificity in therapy development.

Noam Solomon Immunai

Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target

AI biotech expands partnership after uncovering novel immune target with its machine learning platform.

מימין מושיק כהן קוטנר נדב בחנוף חברת אומניקס מדיקל

Omnix Medical raises $25 million Series C to tackle drug-resistant infections

Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.

טליה כהן סולל ו דפנה לייפנפלד

Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment

09.09.25|Maayan Cohen Rozen

BrightKaire uses AI and stem-cell technology to match patients with effective medications, potentially ending years of trial-and-error prescribing.

בדיקת דם מעבדה פתולוגית Pathology laboratory

Israeli biotech Senseera raises $7.1 million Seed round for liquid biopsy platform

The GEM BIOMARKERS technology aims to revolutionize diagnostics in oncology, immunology, and liver disease management.